why choose us

First received: July 20, 2024

Clinical Trial: Association Between Effectiveness of Mirikizumab and UC Patients With High Neutrophilic Infiltration in Epithelium of the Colonic Mucosa

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Ulcerative Colitis

Study Type: INTERVENTIONAL


Official Title: Mirikizumab Therapy is Effective for Patients With Moderate to Severe Ulcerative Colitis Patients Whose Geboes Score Grade is ?3.2) on Endoscopic Biopsy

Brief Summary: The goal of this study is to confirm that Mirikizumab therapy may provide clinical, endoscopic, and histopathologic improvements in patients with moderate to severe UC refractory to maintenance therapy when high neutrophilic infiltration in epithelium of the colonic mucosa (Geboes score Grade ?3.2) on endoscopic biopsy is found.

Read more